BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16412323)

  • 1. [Study of the impact of candidate genes on bone mineral density in postmenopausal women].
    Zhao HY; Liu JM; Ning G; Zhang LZ; Song HD; Chen Y; Jiang L; Dai M; Xu MY; Chen JL
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):803-7. PubMed ID: 16412323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].
    Cheng Q; Zhu HM; Miao YX; Zhu XY; Chen XP; Zhang XM
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):274-7. PubMed ID: 15059506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
    Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
    Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.
    Yamada Y; Ando F; Niino N; Shimokata H
    Mol Genet Metab; 2003 Nov; 80(3):344-9. PubMed ID: 14680982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.
    Vidal C; Brincat M; Xuereb Anastasi A
    Maturitas; 2006 Mar; 53(4):386-95. PubMed ID: 16343827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of calcitonin receptor gene polymorphism with bone mineral density in Shanghai women].
    Zhao HY; Liu JM; Ning G; Zhang LZ; Jiang L; Dai M; Xu MY; Chen JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):258-61. PubMed ID: 12905735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
    Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
    Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
    García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
    Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women.
    Zhao HY; Liu JM; Ning G; Zhao YJ; Zhang LZ; Sun LH; Xu MY; Uitterlinden AG; Chen JL
    Osteoporos Int; 2005 Dec; 16(12):1519-24. PubMed ID: 15782282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Am J Obstet Gynecol; 2005 Apr; 192(4):1087-93. PubMed ID: 15846185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
    Morita A; Iki M; Dohi Y; Ikeda Y; Kagamimori S; Kagawa Y; Matsuzaki T; Yoneshima H; Marumo F;
    Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
    Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
    Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women.
    Sahin G; Polat G; Baethiş S; Milcan A; Baethdatoethlu O; Erdoethan C; Camdeviren H
    Rheumatol Int; 2003 Mar; 23(2):87-91. PubMed ID: 12634942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study.
    Golbahar J; Hamidi A; Aminzadeh MA; Omrani GR
    Bone; 2004 Sep; 35(3):760-5. PubMed ID: 15336613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor gene polymorphisms and bone mineral density in Chinese postmenopausal women.
    Liu J; Zhu H; Zhu X; Dai M; Jiang L; Xu M; Chen J
    Chin Med J (Engl); 2003 Mar; 116(3):364-7. PubMed ID: 12781038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
    Firat SC; Cetin Z; Samanci N; Aydin F; Balci N; Gungor F; Firat MZ; Luleci G; Karauzum SB
    Maturitas; 2009 Aug; 63(4):352-6. PubMed ID: 19520527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.